Alvotech ( ($ALVO) ) just unveiled an announcement. On October 6, 2025, Alvotech announced that the European Medicines Agency accepted a Marketing ...

Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on ...

Alvotech (NasdaqGM:ALVO) has caught some attention in the biotech space recently, especially given its stock movement over the past month. With a 3% increase in that period, investors are wondering ...

Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest ...

EMA accepts marketing authorization application for AVT23, a proposed biosimilar to Xolair: London, UK Tuesday, October 7, 2025, 16:00 Hrs [IST] Advanz Pharma Holdco Limited (Adva ...

ALVO's partnership-driven model fuels surging biosimilar revenues, while TEVA leans on scale but faces debt and competitive pressures.

Alvotech (ALVO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in ...

Friday said that its commercialization partner in Japan, Fuji Pharma Co., Ltd., has received marketing approval for three new biosimilars from the Japanese Ministry of Health, Labor, and Welfare.

REYKJAVIK, Iceland, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, ...

Alvotech ( ($ALVO) ) has provided an announcement. On September 19, 2025, Alvotech announced that its partner in Japan, Fuji Pharma, received ...